In addition, these drugs exhibited preclinical efficacy against breast cancer, 67 neuroblastoma, 68 locally advanced NSCLC, 69 melanoma, 70 and hepatocellular carcinoma in patients with cirrhosis 71 (Figure 3)
Number 4 in outcomes theorist Dr Paul Duignan's Three Minute Outcomes video series
Watch the full briefing: #PeptideMedicine #PatientSafety #FDA #CompoundingPharmacy #503A To view or add a comment, sign in Encouraging to see the clampdown on GLP-1 compounders
Suthipol Udompunturak, MSc, for his advice with statistical analysis
Silibinin is a flavonolignans component extracted from silymarin, which has anti-inflammatory, anti-infective, and anti-tumor effects
The Zone-equivalent calorie-restricted diet produces weight loss while preserving lean body mass in both type 2 diabetes and pre-diabetes patients